Skip to content

Total debt at other companies

Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$3.3M+2.6%
Opko Health logo
Opko HealthOPK
$52.78M-4.2%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.42M-42.5%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$180.9M+69.8%
Erasca, Inc. logo
Erasca, Inc.ERAS
$45.95M-9.6%
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$973.05M+244%
Enterprise value$921.46M+295%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $956K.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s total debt?
Olema Pharmaceuticals, Inc. (OLMA) reported total debt of $956K in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s total debt changed year-over-year?
Olema Pharmaceuticals, Inc.'s total debt decreased by 16.7% year-over-year, from $1.15M to $956K.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s total debt?
Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s total debt has grown at a -22.4% compound annual growth rate (CAGR), from $3.29M to $1.19M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.